We are live on ! Find out more
CORV

Correvio Pharma Corp. Ordinary Shares (Canada)
CORV

Delisted

CORV was delisted on the 26th of May, 2020.

33 hedge funds and large institutions have $85.5M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2015 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 7

25% more capital invested

Capital invested by funds: $68.3M → $85.5M (+$17.2M)

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

3% more funds holding

Funds holding: 3233 (+1)

63% less call options, than puts

Call options by funds: $706K | Put options by funds: $1.91M

Holders
33
Holders Change
+1
Holders Change %
+3.13%
% of All Funds
0.89%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
15
Reduced
7
Closed
5
Calls
$706K
Puts
$1.91M
Net Calls
-$1.21M
Net Calls Change
-$866K

CORV Hedge Fund Activity: Q2 2015 in Review

33 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q2 2015, worth a combined $85.5M — up 25% from $68.3M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CORV positions and 5 closed out — a net gain of 1 holder — while 15 added to existing stakes and 7 trimmed.

The largest buyer was AlphaOne Investment Services, opening a new position worth an estimated $4.95M. The largest seller was Acuta Capital Partners, exiting entirely with an estimated $2.2M sold.

  • 33 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q2 2015, up from 32 in Q1 2015.
  • Funds reported $85.5M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q2 2015, up 25% quarter-over-quarter.
  • 6 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q2 2015 and 5 closed out, a net change of +1 holder.
  • The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q2 2015 was AlphaOne Investment Services, an estimated $4.95M added.
  • The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q2 2015 was Acuta Capital Partners, an estimated $2.2M sold.

Based on aggregated 13F filings for Q2 2015.